Regulation of ferrochelatase gene expression by hypoxia

Life Sciences - Tập 75 - Trang 2035-2043 - 2004
Yunying L. Liu1, Sonny O. Ang2, Douglas A. Weigent3, Josef T. Prchal2, Joseph R. Bloomer1
1Department of Medicine, Liver Center, University of Alabama at Birmingham, Birmingham, AL 35294-0005, USA
2Department of Medicine and Molecular and Human Genetics, Baylor College of Medicine & VAH at Houston, Houston, TX 77030, USA
3Department of Physiology and Biophysics, University of Alabama at Birmingham, Birmingham, AL, 35294, USA

Tài liệu tham khảo

Ang, 2002, Disruption of oxygen homeostasis underlies congenital Chuvash polycythemia, Nature Genetics, 32, 614, 10.1038/ng1019 Asano, 2000, FKLF-2: A novel Kruppel-like transcriptional factor that activates globin and other erythroid lineage genes, Blood, 95, 3578, 10.1182/blood.V95.11.3578 Brenner, 1992, A molecular defect in human protoporphyria, American Journal of Human Genetics, 50, 1203 Brenner, 1991, Cloning of murine ferrochelatase, Proc Natl Acad Sci USA, 88, 849, 10.1073/pnas.88.3.849 Chan, 1993, Expression of ferrochelatase mRNA in erythroid and non-erythroid cells, Biochemical Journal, 292, 343, 10.1042/bj2920343 Conder, 1991, Multiple mechanisms for the regulation of haem synthesis during erythroid cell differentiation: possible role for coproporphyrinogen oxidase, Biochemical Journal, 275, 321, 10.1042/bj2750321 Dailey, 1987, Metal inhibition of ferrochelatase, Annals of New York Academy of Sciences, 514, 81, 10.1111/j.1749-6632.1987.tb48763.x Dailey, 2000, Ferrochelatase at the millennium: Structures, mechanisms and [2Fe–2S] clusters, Cellular Molecular Life Sciences, 57, 1909, 10.1007/PL00000672 Fukuda, 1993, Haem is necessary for a continued increase in ferrochelatase mRNA in murine erythroleukaemia cells during erythroid differentiation, British Journal of Haematology, 85, 670, 10.1111/j.1365-2141.1993.tb03207.x Furukawa, 1995, Nitric oxide-mediated inactivation of mammalian ferrochelatase in vivo and in vitro: possible involvement of the iron-sulphur cluster of the enzyme, Biochemical Journal, 310, 538, 10.1042/bj3100533 Furukawa, 1997, Regulation of the ferrochelatase gene expression during differentiation of mouse erythroleukemia cells, Biochemical and Molecular Biology International, 41, 1161 Hofer, 2003, Hypoxic up-regulation of erythroid 5-aminolevulinate synthase, Blood, 101, 348, 10.1182/blood-2002-03-0773 Ivan, 2001, HIF-alpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing, Science, 292, 464, 10.1126/science.1059817 Karr, 1988, The synthesis of murine ferrochelatase in vitro and in vivo, Biochem J, 254, 799, 10.1042/bj2540799 Lake-Bullock, 1993, Biphasic ordered induction of heme synthesis in differentiating murine erythroleukemia cells: role of erythroid 5-aminolevulinate synthase, Molecular and Cellular Biology, 13, 7122, 10.1128/MCB.13.11.7122 Lando, 2002, Asparagine hydroxylation of the HIF transactivation domain: a hypoxic switch, Science, 295, 858, 10.1126/science.1068592 Lok, 1999, Identification of a hypoxia response element in the transferrin receptor gene, Journal of Biological Chemistry, 274, 24147, 10.1074/jbc.274.34.24147 Magness, 2000, Analysis of ferrochelatase expression during hematopoietic development of embryonic stem cells, Blood, 95, 3568, 10.1182/blood.V95.11.3568 Mappala, 2000, The role of the HNF-1 alpha in controlling hepatic catalase activity, Molecular Pharmacology, 57, 93 Maxwell, 1999, The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis, Nature, 399, 271, 10.1038/20459 Nakahashi, 1990, Molecular cloning and sequence analysis of cDNA encoding human ferrochelatase, Biochem Biophys Res Commun, 173, 748, 10.1016/S0006-291X(05)80099-3 Ponka, 1999, The transferrin receptor: role in health and diseases, International Journal of Biochemistry and Cellular Biology, 31, 1111, 10.1016/S1357-2725(99)00070-9 Rolfs, 1997, Oxygen-regulated transferrin expression is mediated by hypoxia-inducible factor 1, Journal of Biological Chemistry, 272, 20055, 10.1074/jbc.272.32.20055 Rossie, 1990, Inhibition of human hymphocyte ferrochelatase activity by hemin, Biochimica et Biophysica Acta, 1038, 375, 10.1016/0167-4838(90)90251-A Sadlon, 1999, Regulation of erythroid 5-aminolevulinate synthase expression during erythropoiesis, International Journal of Biochemistry and Cellular Biology, 31, 1153, 10.1016/S1357-2725(99)00073-4 Safra, 2003, HIF hydroxylation and the mammalian oxygen-sensing pathway, Journal of Clinical Investigation, 111, 779, 10.1172/JCI200318181 Semenza, 2000, Expression of hypoxia-inducible factor 1: Mechanisms and consequences, Biochemical Pharmacology, 59, 47, 10.1016/S0006-2952(99)00292-0 Semenza, 1992, A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation, Molecular and Cellular Biology, 12, 5447, 10.1128/MCB.12.12.5447 Taketani, 2000, Regulation of the expression of human ferrochelatase by intracellular iron levels, European Journal of Biochemistry, 267, 4685, 10.1046/j.1432-1327.2000.01519.x Taketani, 1999, Structure and regulation of the mouse ferrochelatase gene, Gene, 227, 117, 10.1016/S0378-1119(99)00011-6 Tugores, 1994, A single promoter directs both housekeeping and erythroid preferential expression of the human ferrochelatase gene, Journal of Biological Chemistry, 269, 30789, 10.1016/S0021-9258(18)47351-6